Progress in basic and clinical and clinical research of a cell therapy for end-stage liver disease
10.3760/cma.j.cn501113-20190325-00094
- VernacularTitle:细胞治疗终末期肝病基础与临床研究进展
- Author:
Lei SHI
1
;
Ming SHI
;
Fanping MENG
;
Fusheng WANG
Author Information
1. 解放军总医院第五医学中心感染病医学部 国家感染性疾病临床医学研究中心，北京 100039
- Keywords:
End stage liver disease;
Cells;
Therapy
- From:
Chinese Journal of Hepatology
2021;29(2):179-182
- CountryChina
- Language:Chinese
-
Abstract:
Clinically, the incidence of end-stage liver disease including decompensated cirrhosis and liver failure is high, which seriously threatens people’s health. The existing comprehensive internal medicine treatment is ineffective, and liver transplantation is still the most effective treatment method. However, the shortage of matching liver donors and other reasons constrain the development of liver transplantation, thus limiting the treatment of patients with end-stage liver disease. In recent years, domestic and foreign scholars have conducted many pre-clinical and clinical trials using a variety of cells, and have achieved certain results, providing a new method for the treatment of end-stage liver disease. This article reviews and discusses the existing problems, research status and application progress of varieties of cell therapy for end-stage liver diseases.
